South Korea · Delayed Price · Currency is KRW Amicogen Statistics
Total Valuation
Amicogen has a market cap or net worth of KRW 133.16 billion. The enterprise value is 231.99 billion.
| Market Cap | 133.16B |
| Enterprise Value | 231.99B |
Important Dates
The next estimated earnings date is Thursday, May 14, 2026.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Amicogen has 70.45 million shares outstanding. The number of shares has increased by 0.44% in one year.
| Current Share Class | 70.45M |
| Shares Outstanding | 70.45M |
| Shares Change (YoY) | +0.44% |
| Shares Change (QoQ) | +0.96% |
| Owned by Insiders (%) | 3.84% |
| Owned by Institutions (%) | 0.27% |
| Float | 64.99M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.17 |
| PB Ratio | 1.25 |
| P/TBV Ratio | 1.52 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -7.74 |
| EV / Sales | 5.53 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -8.25 |
Financial Position
The company has a current ratio of 0.54, with a Debt / Equity ratio of 0.88.
| Current Ratio | 0.54 |
| Quick Ratio | 0.32 |
| Debt / Equity | 0.88 |
| Debt / EBITDA | n/a |
| Debt / FCF | -3.35 |
| Interest Coverage | -1.98 |
Financial Efficiency
Return on equity (ROE) is -25.42% and return on invested capital (ROIC) is -7.82%.
| Return on Equity (ROE) | -25.42% |
| Return on Assets (ROA) | -3.65% |
| Return on Invested Capital (ROIC) | -7.82% |
| Return on Capital Employed (ROCE) | -9.50% |
| Weighted Average Cost of Capital (WACC) | 5.48% |
| Revenue Per Employee | 177.89M |
| Profits Per Employee | -126.95M |
| Employee Count | 236 |
| Asset Turnover | 0.16 |
| Inventory Turnover | 3.13 |
Taxes
In the past 12 months, Amicogen has paid 491.17 million in taxes.
| Income Tax | 491.17M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -44.25% in the last 52 weeks. The beta is 0.09, so Amicogen's price volatility has been lower than the market average.
| Beta (5Y) | 0.09 |
| 52-Week Price Change | -44.25% |
| 50-Day Moving Average | 1,608.30 |
| 200-Day Moving Average | 2,702.70 |
| Relative Strength Index (RSI) | 53.98 |
| Average Volume (20 Days) | 1,061,575 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Amicogen had revenue of KRW 41.98 billion and -29.96 billion in losses. Loss per share was -543.00.
| Revenue | 41.98B |
| Gross Profit | 5.29B |
| Operating Income | -15.37B |
| Pretax Income | -29.87B |
| Net Income | -29.96B |
| EBITDA | -5.74B |
| EBIT | -15.37B |
| Loss Per Share | -543.00 |
Balance Sheet
The company has 7.24 billion in cash and 94.15 billion in debt, with a net cash position of -86.91 billion or -1,233.54 per share.
| Cash & Cash Equivalents | 7.24B |
| Total Debt | 94.15B |
| Net Cash | -86.91B |
| Net Cash Per Share | -1,233.54 |
| Equity (Book Value) | 106.50B |
| Book Value Per Share | 1,701.07 |
| Working Capital | -32.21B |
Cash Flow
In the last 12 months, operating cash flow was -24.42 billion and capital expenditures -3.71 billion, giving a free cash flow of -28.13 billion.
| Operating Cash Flow | -24.42B |
| Capital Expenditures | -3.71B |
| Depreciation & Amortization | 9.63B |
| Net Borrowing | -47.92B |
| Free Cash Flow | -28.13B |
| FCF Per Share | -399.31 |
Margins
Gross margin is 12.60%, with operating and profit margins of -36.62% and -71.36%.
| Gross Margin | 12.60% |
| Operating Margin | -36.62% |
| Pretax Margin | -71.16% |
| Profit Margin | -71.36% |
| EBITDA Margin | -13.68% |
| EBIT Margin | -36.62% |
| FCF Margin | n/a |
Dividends & Yields
Amicogen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.44% |
| Shareholder Yield | -0.44% |
| Earnings Yield | -22.50% |
| FCF Yield | -21.13% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 13, 2023. It was a forward split with a ratio of 2.
| Last Split Date | Dec 13, 2023 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Amicogen has an Altman Z-Score of 0.3 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.3 |
| Piotroski F-Score | 2 |